K-numberK253532
Device nameTruSPECT Processing Station
ApplicantSpectrum Dynamics Medical, Ltd.
Product codeQIH
Device classClass II
Decision dateDec 30, 2025
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The TruSPECT Processing Station is a software-only medical device for accepting, displaying, storing, and processing nuclear medicine images (SPECT) to detect radioisotope tracer uptakes in patients. It includes visualization tools, quantitative analysis features for cardiac applications (QPS, QGS, QBS), and can integrate with CT/MR scans for diagnostic purposes. The device operates on Windows and can be configured with various clinical applications and post-processing software modules.

Technological characteristics

The modified TruSPECT maintains identical fundamental technological characteristics to its predicate device, including manual and automatic segmentation tools and support for multiple imaging modalities. The primary modification is the addition of the TruClear AI module, an artificial intelligence–based post-processing component designed to reduce noise in low-count D-SPECT myocardial perfusion images while using pre-trained neural networks in iterative reconstruction and traditional image processing algorithms. This does not alter the system's intended use, indications for use, or fundamental software architecture.

Test standards cited

Testing was performed in compliance with NEMA PS3.1–3.20, IEC 62304, 21 CFR 820, and ISO 13485. Verification and validation activities included software verification, system integration and performance testing, simulated-use testing, and risk-based assessments. Clinical validation used FDA-cleared Cedars-Sinai QPS/QGS for quantitative parameter derivation and independent board-certified nuclear medicine physician review using 5-point Likert scales.

Substantial equivalence argument

The proposed device has identical intended use and technological characteristics to the predicate (K212230), with the addition of TruClear AI not raising new safety or effectiveness concerns. Verification and validation testing confirmed the system meets all performance specifications, maintains the same safety and effectiveness profile, and operates within intended parameters. The AI module's quantitative performance demonstrated strong correlation (e.g., LVEF r=0.94, TPD r=0.98) to high-count reference images with results meeting pre-specified acceptance criteria.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →